Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.1.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.26EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.26ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.26ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.26EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.26EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.22EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.22ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.22ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.22EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.22EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.21EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.5.2.21ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.21ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
BA.5.2.21EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.21EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
BA.5.2.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BA.5.1.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used